- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01891656
Motivational Assessment Program to Initiate Treatment (MAPIT)
11 aprile 2016 aggiornato da: University of North Texas Health Science Center
In-Person VS. Computer Interventions for Increasing Probation Compliance
Substance abuse treatment in the criminal justice system can reduce drug use and related criminal behavior.
Although drug and alcohol treatment are common mandates in criminal justice programs, only a minority of clients actually initiate treatment.
This proposal will compare two intervention formats that target motivation to initiate and engage in treatment among a group of probationers who have drug or alcohol treatment conditions.
Six hundred drug and alcohol offenders in two probation sites (Baltimore, MD and Dallas, TX) will be randomized to receive: 1) an in-person motivational interviewing session (MI), 2) a motivational computer program (MC), or 3) supervision intake and monitoring as usual (SAU).
The MI condition will be structured along the lines of the "Check-Up" format which consists of an assessment and personalized feedback delivered in an MI style; the content of the MC condition will be drawn from previous literature on effective motivational computer programs.
Both interventions will be delivered at the start of the probation process, with follow-up assessments at 2 and 6 months.
Primary outcomes include engagement and participation in substance abuse treatment; secondary outcomes include drug and alcohol use, probation progress, criminal behavior, and HIV testing and care.
This project will be the first to develop and test two interventions for encouraging criminal justice clients to follow through with treatment recommendations, with the goal of increasing treatment initiation, and reducing subsequent drug use and criminal behavior.
It also contributes to ongoing partnerships with two large probation agencies-the Dallas County Supervision and Corrections Department and the Maryland Division of Parole and Probation.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Specific Aims
- Develop two intervention formats (Motivational Interviewing (MI) and Motivational Computer (MC)) for increasing motivation to initiate and engage in substance abuse treatment and/or HIV / AIDS testing and, if appropriate, HIV care.
- Test the efficacy of MI and MC on treatment initiation and participation, substance abuse, HIV testing/care, and recidivism, as compared to Supervision As Usual (SAU);
- Evaluate offender characteristics (e.g., risk level, gender, ethnicity, motivation) as potential moderators of the intervention effect; and,
- Assess the relative cost and cost-effectiveness of MI and MC on substance abuse treatment and/or linkage to or participation in HIV/AIDS care, supervision outcomes, recidivism, and substance abuse.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
380
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Texas
-
Fort Worth, Texas, Stati Uniti, 76107
- University of North Texas Health Science Center
-
-
Virginia
-
Fairfax, Virginia, Stati Uniti, 22030
- George Mason University
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
18 anni e precedenti (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- >=18 years old
- Drug or Alcohol use in the last 90 days
Exclusion Criteria:
- <18 years old
- Cannot speak English
- Already participate in a substance abuse treatment
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Motivational Interviewing
Participants randomized to the MI group will receive a single 60-minute MI session focused on motivation to initiate and engage in treatment.
The MI session will be organized around the "Check-Up" format, with additional planning components as desired by the client.
|
MI is a "client centered, directive style of interacting with a person to help explore and resolve ambivalence about change" (Miller & Rollnick, 2002).
MI borrows from Client-Centered Counseling in its emphasis on empathy, optimism, and respect for client choice (Rogers, 1961).
MI also draws from Self-Perception Theory, which says that a person becomes more or less committed to an action based on the verbal stance he or she takes (Bem, 1972).
The effects of MI tend to be in the small-to-medium range when compared to no treatment, and nonsignificant when compared to more extensive treatment.
Altri nomi:
|
|
Nessun intervento: Supervision As Usual
Participants randomized to the SAU group will receive the standard agency intake process as well as baseline and follow-up research interviews, but will not receive any additional intervention as part of the study.
They will be referred to a treatment program as per the normal routine.
|
|
|
Sperimentale: Motivational Computer
Participants randomized to the MC group will complete a 60 minute computer intervention focused on motivation to initiate and engage in treatment.
The program will be self-guided, interactive, and to the extent possible, will mirror the features of MI session.
The MC program will have two main components: a motivation component and a planning component.
|
The growing use of technology has led to the development of automated interventions for behavior change, including some that target drug and alcohol use (Elliott, et al, 2008; Lustria, et al, 2009; Revere & Dunbar, 2001; Walters, et al, 2006) and treatment interest (Lieberman & Massey, 2008).
As discussed by Hester & Miller (2006), automated interventions have several potential advantages over face-to-face interventions: (I) They require little or no staff contact, which may increase cost-effectiveness; (2) they can allow for automatic data collection and follow-up; and (3) they can be disseminated with little loss of fidelity.
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Treatment Progress
Lasso di tempo: 6 months
|
Treatment progress assesses initiation, engagement and retention at 2 and 6 months via telephone.
In-person visits are assessed at baseline and during a 6 month visit.
|
6 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Drug and Alcohol Use
Lasso di tempo: 6 months
|
Drug and alcohol use is a secondary outcome measured at baseline and 6 months during an in-person interview.
In addition, this outcome is measured at 2 via telephone.
|
6 months
|
|
Probation Progress
Lasso di tempo: 6 months
|
Probation progress is measured at baseline and 6 months via in-person interview.
In addition, this outcome is measured at 2 via a telephone interview.
|
6 months
|
|
Criminal Behavior
Lasso di tempo: 6 months
|
Criminal Behavior is measured during in-person interviews at baseline and 6 months.
In addition, this outcome is measured at 2 months via telephone.
|
6 months
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Collaboratori
Investigatori
- Investigatore principale: Scott T Walters, PhD, UNT Health Science Center
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Pubblicazioni generali
- Walters ST, Ondersma SJ, Ingersoll KS, Rodriguez M, Lerch J, Rossheim ME, Taxman FS. MAPIT: development of a web-based intervention targeting substance abuse treatment in the criminal justice system. J Subst Abuse Treat. 2014 Jan;46(1):60-5. doi: 10.1016/j.jsat.2013.07.003. Epub 2013 Aug 16.
- Reingle Gonzalez JM, Walters ST, Lerch J, Taxman FS. The Relationship Between Drug Use, Drug-related Arrests, and Chronic Pain Among Adults on Probation. J Subst Abuse Treat. 2015 Jun;53:33-8. doi: 10.1016/j.jsat.2014.12.005. Epub 2014 Dec 30.
- Rodriguez M, Walters ST, Houck JM, Ortiz JA, Taxman FS. The language of change among criminal justice clients: Counselor language, client language, and client substance use outcomes. J Clin Psychol. 2018 Apr;74(4):626-636. doi: 10.1002/jclp.22534. Epub 2017 Sep 22.
- Lerch J, Walters ST, Tang L, Taxman FS. Effectiveness of a computerized motivational intervention on treatment initiation and substance use: Results from a randomized trial. J Subst Abuse Treat. 2017 Sep;80:59-66. doi: 10.1016/j.jsat.2017.07.002. Epub 2017 Jul 6.
- Spohr SA, Taxman FS, Rodriguez M, Walters ST. Motivational Interviewing Fidelity in a Community Corrections Setting: Treatment Initiation and Subsequent Drug Use. J Subst Abuse Treat. 2016 Jun;65:20-5. doi: 10.1016/j.jsat.2015.07.012. Epub 2015 Jul 29.
- Taxman FS, Walters ST, Sloas LB, Lerch J, Rodriguez M. Motivational tools to improve probationer treatment outcomes. Contemp Clin Trials. 2015 Jul;43:120-8. doi: 10.1016/j.cct.2015.05.016. Epub 2015 May 22.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
1 giugno 2012
Completamento primario (Effettivo)
1 giugno 2015
Completamento dello studio (Effettivo)
1 febbraio 2016
Date di iscrizione allo studio
Primo inviato
18 ottobre 2011
Primo inviato che soddisfa i criteri di controllo qualità
28 giugno 2013
Primo Inserito (Stima)
3 luglio 2013
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
13 aprile 2016
Ultimo aggiornamento inviato che soddisfa i criteri QC
11 aprile 2016
Ultimo verificato
1 aprile 2016
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- R01DA029010-01 (Sovvenzione/contratto NIH degli Stati Uniti)
- 5R01DA029010-06 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Disturbi Correlati a Sostanze
-
Charite University, Berlin, GermanyReclutamentoSchizofrenia Spectrum Disorders (SSD)Germania
-
Università degli Studi di BresciaAttivo, non reclutanteDisturbo bipolare (BD) | Schizofrenia Spectrum Disorders (SSD)Italia
-
University of Trás-os-Montes and Alto DouroCentro Hospitalar De Trás-Os-Montes E Alto Douro, E.P.E.ReclutamentoDisturbi psicotici | Grave malattia mentale | Schizofrenia Spectrum Disorders (SSD)Portogallo
-
Central Institute of Mental Health, MannheimReclutamentoSchizofrenia Spectrum Disorders (SSD)Germania
-
Tianjin Medical University General HospitalReclutamentoNeuromielite Optica Spectrum Disorders (NMOSD)Cina
-
Tianjin Medical University General HospitalNon ancora reclutamentoNeuromielite ottica (NMO) | Neuromielite Optica Spectrum Disorders (NMOSD)
-
Huashan HospitalNon ancora reclutamentoNeuromielite Optica Spectrum Disorders (NMOSD)Cina
-
Huashan HospitalCompletato
-
Huashan HospitalShanghai AbelZeta Ltd.Non ancora reclutamentoEncefalite autoimmune | Sclerosi multipla (SM) | Sindrome della persona rigida | Neuromielite Optica Spectrum Disorders (NMOSD)
-
RenJi HospitalAbelZeta Pharma Inc.ReclutamentoMiastenia grave | Lupus eritematoso sistemico (LES) | Sclerosi multipla (SM) | Sclerosi sistemica (SSc) | Miopatia necrotizzante immunomediata (IMNM) | Neuromielite Optica Spectrum Disorders (NMOSD)Cina